(Q44193431)

English

Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis

scientific article published in November 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

Alfonso E. Bello

3

object named as

Alfonso E Bello

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

author name string

Andrew Whelton

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

William B White

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Joseph A Puma

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

John G Fort

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

SUCCESS-VII Investigators

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

90

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

959-963

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902661-9

7 January 2021

Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902661-9

7 January 2021

Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902661-9

7 January 2021

Effect of indomethacin on the renal response to angiotensin II receptor blockade in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902661-9

7 January 2021

Influence of non-steroidal anti-inflammatory drugs on renal function and 24h ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients

2 references

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902661-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902661-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of celecoxib and naproxen on renal function in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902661-9

7 January 2021

Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902661-9

7 January 2021

Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902661-9

7 January 2021

Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902661-9

7 January 2021

Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902661-9

7 January 2021

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902661-9

7 January 2021

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902661-9

7 January 2021

Risk of cardiovascular events associated with selective COX-2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902661-9

7 January 2021

Biomedicine. Back to an aspirin a day?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902661-9

7 January 2021

The coxibs, selective inhibitors of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902661-9

7 January 2021

Selective COX-2 Inhibitors, NSAIDs, aspirin, and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902661-9

7 January 2021

Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902661-9

7 January 2021

Identifiers

10.1016/S0002-9149(02)02661-9

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44193431&oldid=2108397297"